John M. Lindlof

Array ( [id] => 3783116 [patent_doc_number] => 05821224 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Antimicrobial peptides from bovine neutrophils' [patent_app_type] => 1 [patent_app_number] => 8/356832 [patent_app_country] => US [patent_app_date] => 1994-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 49 [patent_no_of_words] => 12425 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821224.pdf [firstpage_image] =>[orig_patent_app_number] => 356832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3668268 [patent_doc_number] => 05599919 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Nucleic acid encoding a transiently-expressed kinetochore protein, and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/353700 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10663 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599919.pdf [firstpage_image] =>[orig_patent_app_number] => 353700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3678764 [patent_doc_number] => 05632992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Process for the expression of herpes simplex virus type 1 glycoprotein E and method of use' [patent_app_type] => 1 [patent_app_number] => 8/353948 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6212 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/632/05632992.pdf [firstpage_image] =>[orig_patent_app_number] => 353948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151188 [patent_doc_number] => 06113951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins' [patent_app_type] => 1 [patent_app_number] => 8/211673 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 63 [patent_no_of_words] => 29786 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113951.pdf [firstpage_image] =>[orig_patent_app_number] => 211673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586941 [patent_doc_number] => 05550049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Process for identifying para cation channel modulators' [patent_app_type] => 1 [patent_app_number] => 8/338702 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10400 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550049.pdf [firstpage_image] =>[orig_patent_app_number] => 338702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403648 [patent_doc_number] => 06538121 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Interleukin-1 converting enzyme like apoptosis protease-3 and 4' [patent_app_type] => B1 [patent_app_number] => 08/334251 [patent_app_country] => US [patent_app_date] => 1994-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11183 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538121.pdf [firstpage_image] =>[orig_patent_app_number] => 08334251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655593 [patent_doc_number] => 05622852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Bcl-x/Bcl-2 associated cell death regulator' [patent_app_type] => 1 [patent_app_number] => 8/333565 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 34 [patent_no_of_words] => 35645 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622852.pdf [firstpage_image] =>[orig_patent_app_number] => 333565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528766 [patent_doc_number] => 05583016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Mammalian telomerase' [patent_app_type] => 1 [patent_app_number] => 8/330123 [patent_app_country] => US [patent_app_date] => 1994-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13930 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583016.pdf [firstpage_image] =>[orig_patent_app_number] => 330123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3509307 [patent_doc_number] => 05587311 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'DNA encoding a cell membrane glycoprotein of a tick gut' [patent_app_type] => 1 [patent_app_number] => 8/325071 [patent_app_country] => US [patent_app_date] => 1994-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 20 [patent_no_of_words] => 26192 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587311.pdf [firstpage_image] =>[orig_patent_app_number] => 325071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3101729 [patent_doc_number] => 05447860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'Tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/323474 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13291 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447860.pdf [firstpage_image] =>[orig_patent_app_number] => 323474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3719964 [patent_doc_number] => 05672349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/310370 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4687 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672349.pdf [firstpage_image] =>[orig_patent_app_number] => 310370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3587063 [patent_doc_number] => 05516674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Insecticide resistance associated cytochrome 450' [patent_app_type] => 1 [patent_app_number] => 8/298426 [patent_app_country] => US [patent_app_date] => 1994-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7765 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516674.pdf [firstpage_image] =>[orig_patent_app_number] => 298426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3607068 [patent_doc_number] => 05589359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Chimeric proteins' [patent_app_type] => 1 [patent_app_number] => 8/286521 [patent_app_country] => US [patent_app_date] => 1994-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 13316 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589359.pdf [firstpage_image] =>[orig_patent_app_number] => 286521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725072 [patent_doc_number] => 05672684 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Recombinant human rotavirus VP7 serotype 4' [patent_app_type] => 1 [patent_app_number] => 8/280016 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4367 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672684.pdf [firstpage_image] =>[orig_patent_app_number] => 280016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3681255 [patent_doc_number] => 05633152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Method of controlling viral growth' [patent_app_type] => 1 [patent_app_number] => 8/280247 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3298 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633152.pdf [firstpage_image] =>[orig_patent_app_number] => 280247 [rel_patent_id] =>[rel_patent_doc_number] =>)